Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0IZ1D
|
|||
| Former ID |
DIB009881
|
|||
| Drug Name |
Brofaromine
|
|||
| Synonyms |
Brofaremine; Consonar; Consonev; Brofaromine hydrochloride; CGP-11305A
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Anxiety disorder [ICD-11: 6B00-6B0Z; ICD-10: R45.0] | Discontinued in Phase 2 | [1] | |
| Company |
Novartis AG
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H16BrNO2
|
|||
| Canonical SMILES |
COC1=CC(=C2C(=C1)C=C(O2)C3CCNCC3)Br
|
|||
| InChI |
1S/C14H16BrNO2/c1-17-11-6-10-7-13(9-2-4-16-5-3-9)18-14(10)12(15)8-11/h6-9,16H,2-5H2,1H3
|
|||
| InChIKey |
WZXHSWVDAYOFPE-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 63638-91-5
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000689) | |||
| REF 2 | Preclinical profiles of the novel reversible MAO-A inhibitors, moclobemide and brofaromine, in comparison with irreversible MAO inhibitors. J Neural Transm Suppl. 1989;28:5-20. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.